Yuna Larrabee, MD | |
500 Congress St Ste 2b, Quincy, MA 02169-0960 | |
(617) 774-1717 | |
Not Available |
Full Name | Yuna Larrabee |
---|---|
Gender | Female |
Speciality | Otolaryngology |
Experience | 13 Years |
Location | 500 Congress St Ste 2b, Quincy, Massachusetts |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1386933117 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Y00000X | Otolaryngology | 271657 (Massachusetts) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Massachusetts Eye And Ear Infirmary - | Boston, MA | Hospital |
Brigham And Women's Hospital | Boston, MA | Hospital |
South Shore Hospital | South weymouth, MA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Massachusetts Eye And Ear Associates, Inc | 4486540275 | 337 |
News Archive
While Connecticut GOP candidates appear to be distancing themselves from the Medicare plans being advanced by their presidential candidate Mitt Romney, the U.S. Chamber of Commerce has expanded its advertising targeting Democrats who voted in favor of the health law.
Employees with diabetes are not automatically more tired due to a combination of work and illness. However, Dutch researcher Iris Weijman found that employees with diabetes who have several chronic conditions and those who experience inconvenience from their illness do have a higher risk of fatigue.
PLAYING tennis could beat going to the gym when it comes to warding-off muscle and bone problems later in life, according to a groundbreaking new study.
Dr. Katja F-lber and Professor Oliver Daumke, structural biologists at the Max Delbr-ck Center for Molecular Medicine (MDC) Berlin-Buch, together with researchers from Freie Universit-t (FU) Berlin, have determined the molecular structure of dynamin, a 'wire-puller' that mediates nutrient uptake into the cell.
Drug discovery and development company Esperance Pharmaceuticals today announced that it has begun enrollment and dosing of patients in a Phase 1 study of EP-100 in patients with advanced solid tumors. EP-100, the lead candidate from Esperance's Cationic Lytic Peptide (CLYP(TM)) platform technology, is a targeted membrane-disrupting peptide (tMDP) designed to seek and destroy cancer cells that over-express luteinizing hormone releasing hormone (LHRH) receptors on their surfaces.
› Verified 4 days ago
Entity Name | Massachusetts Eye And Ear Associates, Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1932574332 PECOS PAC ID: 4486540275 Enrollment ID: O20040227000123 |
News Archive
While Connecticut GOP candidates appear to be distancing themselves from the Medicare plans being advanced by their presidential candidate Mitt Romney, the U.S. Chamber of Commerce has expanded its advertising targeting Democrats who voted in favor of the health law.
Employees with diabetes are not automatically more tired due to a combination of work and illness. However, Dutch researcher Iris Weijman found that employees with diabetes who have several chronic conditions and those who experience inconvenience from their illness do have a higher risk of fatigue.
PLAYING tennis could beat going to the gym when it comes to warding-off muscle and bone problems later in life, according to a groundbreaking new study.
Dr. Katja F-lber and Professor Oliver Daumke, structural biologists at the Max Delbr-ck Center for Molecular Medicine (MDC) Berlin-Buch, together with researchers from Freie Universit-t (FU) Berlin, have determined the molecular structure of dynamin, a 'wire-puller' that mediates nutrient uptake into the cell.
Drug discovery and development company Esperance Pharmaceuticals today announced that it has begun enrollment and dosing of patients in a Phase 1 study of EP-100 in patients with advanced solid tumors. EP-100, the lead candidate from Esperance's Cationic Lytic Peptide (CLYP(TM)) platform technology, is a targeted membrane-disrupting peptide (tMDP) designed to seek and destroy cancer cells that over-express luteinizing hormone releasing hormone (LHRH) receptors on their surfaces.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Yuna Larrabee, MD 500 Congress St Ste 2b, Quincy, MA 02169-0960 Ph: (617) 774-1717 | Yuna Larrabee, MD 500 Congress St Ste 2b, Quincy, MA 02169-0960 Ph: (617) 774-1717 |
News Archive
While Connecticut GOP candidates appear to be distancing themselves from the Medicare plans being advanced by their presidential candidate Mitt Romney, the U.S. Chamber of Commerce has expanded its advertising targeting Democrats who voted in favor of the health law.
Employees with diabetes are not automatically more tired due to a combination of work and illness. However, Dutch researcher Iris Weijman found that employees with diabetes who have several chronic conditions and those who experience inconvenience from their illness do have a higher risk of fatigue.
PLAYING tennis could beat going to the gym when it comes to warding-off muscle and bone problems later in life, according to a groundbreaking new study.
Dr. Katja F-lber and Professor Oliver Daumke, structural biologists at the Max Delbr-ck Center for Molecular Medicine (MDC) Berlin-Buch, together with researchers from Freie Universit-t (FU) Berlin, have determined the molecular structure of dynamin, a 'wire-puller' that mediates nutrient uptake into the cell.
Drug discovery and development company Esperance Pharmaceuticals today announced that it has begun enrollment and dosing of patients in a Phase 1 study of EP-100 in patients with advanced solid tumors. EP-100, the lead candidate from Esperance's Cationic Lytic Peptide (CLYP(TM)) platform technology, is a targeted membrane-disrupting peptide (tMDP) designed to seek and destroy cancer cells that over-express luteinizing hormone releasing hormone (LHRH) receptors on their surfaces.
› Verified 4 days ago
Alex Grilli, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 500 Congress St, Quincy, MA 02169 Phone: 617-774-1717 | |
Peter S Ambrus, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 500 Congress St, Suite 2-a, Quincy, MA 02169 Phone: 617-376-8840 | |
Dr. Edward J. Reardon, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 500 Congress St, Suite 2b, Quincy, MA 02169 Phone: 617-774-1717 | |
Dr. Paul M. Konowitz, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 500 Congress St, Suite 2b, Quincy, MA 02169 Phone: 617-774-1717 | |
Natalia Kyriazidis, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 500 Congress St Ste 2b, Quincy, MA 02169 Phone: 617-774-1717 | |
Dr. Peter N. Friedensohn, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 500 Congress St, Suite 2b, Quincy, MA 02169 Phone: 617-774-1717 |